Authors:
Stevenson, JP
Redlinger, M
Kluijtmans, LAJ
Sun, WJ
Algazy, K
Giantonio, B
Haller, DG
Hardy, C
Whitehead, AS
O'Dwyer, PJ
Citation: Jp. Stevenson et al., Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer, J CL ONCOL, 19(20), 2001, pp. 4081-4087